HopeStage
Back to all studies
CompletedNCT00045916

Two ECT approaches with medication for a major depressive episode

About this titleRead the official source — NCT00045916
Medication studyAges 18+United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
St Louis and 3 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2001
Recruitment status
Completed
Enrollment listed in the registry
340
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Procedure
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00045916
Official title
Show the full official title

Optimization of Electroconvulsive Therapy

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

St Louis · New York · Winston-Salem

1 more locations
  • Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Nortriptyline, Venlafaxine and lithium.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies